The increased risk of developing CVD in HT patients may be caused by proinflammatory mediators, the cytotoxic effects of autoantibodies, autoreactive lymphocytes and abnormal hormone levels (Figure 1) [40,41,42]
Rachele to break down what the science tells us and where Restores IV Drip Therapy can play a role in keeping this essential antioxidant working at its best
doi: 10.1001/jama.2020.12839 21
Baseline and follow-up labs help tailor dosing and prevent overuse
DECLARATIONS Authors contributions Performed literature search, review writing, data analysis, and interpretation: Ding M Made significant contributions to the conception, design, and revision of the manuscript: Luo Y Proposed the rationale and framework of review, provided guidance for manuscript design: Ji L Availability of data and materials Not applicable